| View |
|
DRP-10975
|
Co-Amoxiclav
|
Clavmari-1200
|
1.2 g
|
Powder for Injection (IV)
|
-
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
-
|
28 December 2021
|
28 December 2026
|
| View |
|
DRP-10960
|
Cefuroxime (as sodium)
|
Ceftrinova 1000
|
1 g
|
Powder for Injection (I.V/I.M)
|
Antibacterial (Third-generation Cephalosporin)
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial
|
22 December 2021
|
22 December 2026
|
| View |
|
DRP-10997
|
Hydroxychloroquine sulfate
|
None
|
200mg
|
Tablet
|
-
|
Laurus Labs Limited (Unit 2)
|
India
|
Initial (Correction)
|
23 January 2023
|
29 December 2026
|
| View |
|
DRP-10955
|
Dexamethasone phosphate (as sodium)
|
Novaxameth
|
1 mg/mL (0.1% w/v)
|
Sterile Ophthalmic Solution (Eye
Drops)
|
-
|
Ahlcon Parenterals (India) Limited
|
India
|
-
|
29 December 2021
|
29 December 2026
|
| View |
|
DRP-10908
|
Imipenem (as monohydrate) + Cilastatin (as sodium)
|
Imaxin
|
500 mg/500 mg
|
Powder for Injection (I.V.)
|
-
|
CSPC Ouyi Pharmaceutical Co. Ltd.
|
China
|
-
|
15 December 2021
|
15 December 2026
|
| View |
|
DRP-10959
|
Ceftriaxone (as Sodium)
|
Mitriax 1
|
1 g
|
Powder For Injection (IV/IM)
|
Antibacterial (Third-generation cephalosporin)
|
Makcur Laboratories Limited
|
India
|
Initial
|
22 December 2021
|
22 December 2026
|
| View |
|
DR-XY47616
|
Telmisartan
|
Telmez
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Ajanta Pharma Limited
|
India
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
DR-XY47615
|
Telmisartan
|
Telmez
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Ajanta Pharma Limited
|
India
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
DR-XY44421
|
Progesterone
|
Celoestan 100
|
100mg
|
Softgel Capsule
|
-
|
Celogen Pharma Pvt. Ltd.
|
India
|
-
|
16 December 2021
|
08 April 2025
|
| View |
|
DR-XY44495
|
Progesterone
|
Gestron
|
200mg
|
Softgel Capsule
|
-
|
Celogen Pharma Pvt. Ltd.
|
India
|
-
|
16 December 2021
|
22 April 2025
|
| View |
|
DRP-10943
|
Sitagliptin (As Hydrochloride) + Metformin Hydrochloride
|
Sitazit-M
|
50 mg/1 g
|
Film-Coated Tablet
|
-
|
Hetero Labs Limited (Unit-V, Block-VB)
|
India
|
-
|
21 December 2021
|
21 December 2026
|
| View |
|
DRP-3579
|
Citicoline
|
Tycol
|
250 mg/mL (500 mg/2mL)
|
Solution For Injection (I.V./I.M.)
|
Nootropic
|
Shin Poong Pharmaceutical Co., Limited
|
Korea
|
Renewal
|
16 January 2024
|
04 April 2029
|
| View |
|
DRP-3579-01
|
Citicoline
|
Miracholine
|
250 mg/mL (500 mg/2mL)
|
Solution for Injection
(I.V./I.M.)
|
Nootropic
|
Shin Poong Pharmaceutical Co., Limited
|
Korea
|
Renewal
|
12 February 2024
|
04 April 2029
|
| View |
|
DRP-5347
|
Losartan potassium + Amlodipine (as camsilate)
|
Cozaar XQ
|
100 mg/5 mg
|
Film-Coated Tablet
|
-
|
Hanmi Pharmaceutical Co., Ltd.
|
Korea
|
Monitored Release
|
21 December 2021
|
17 May 2025
|
| View |
|
DRP-10961
|
Ceftriaxone (as Sodium)
|
BESTRICARE
|
1 g
|
Powder for Injection (I.M/I.V.
|
Antibacterial (Third-generation Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
Initial
|
22 December 2021
|
22 December 2026
|
| View |
|
DR-XY40907
|
Losartan potassium + Amlodipine (as camsilate)
|
Cozaar XQ
|
50 mg/5 mg
|
Film-Coated Tablet
|
-
|
Hanmi Pharmaceutical Co., Ltd.
|
Korea
|
Monitored Release
|
21 December 2021
|
17 May 2025
|
| View |
|
DRP-10936
|
Fusidic Acid
|
Sudif
|
20 mg/g (2% w/w)
|
Topical Cream
|
-
|
Scott-Edil Pharmacia Limited
|
India
|
Initial
|
20 December 2021
|
20 December 2026
|
| View |
|
DRP-10935
|
Mometasone Furoate
|
Mfsone
|
10 mg/g (0.1% w/w)
|
Topical Cream
|
-
|
Scott-Edil Pharmacia Limited
|
India
|
Initial
|
20 December 2021
|
20 December 2026
|
| View |
|
DR-XY13929
|
Salbutamol (as Sulfate)
|
Asmar
|
2mg/5mL
|
Syrup
|
-
|
St. Martin Pharmaceutical Laboratories
|
Philippines
|
-
|
16 December 2021
|
10 April 2025
|
| View |
|
HMRP-39
|
Vitex Negundo L. (Lagundi Leaf)
|
Clircaf
|
300mg/5mL
|
Syrup (Mint with Honey Flavor)
|
-
|
Lifesquare Laboratories Inc.
|
Philippines
|
-
|
22 December 2021
|
22 December 2026
|